missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ West Nile Virus Envelope Synthetic Peptide
Descripción
West Nile Virus Envelope Synthetic Peptide, PEP-0222, from Invitrogen.
West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation.
Especificaciones
Especificaciones
| Especie | Virus |
| Método de purificación | purified |
| Nombre común | West Nile Virus Envelope |
| Concentración | 200 μg/mL |
| Contenido y almacenamiento | -20°C |
| Descripción | Synthetic Peptide |
| Formato | Liquid |
| Formulación | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Para utilizar con (aplicación) | Blocking Assay, Control |
| Liofilizado | No |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?